First Clinical Trial for Corneal Disease Treatment Using iPS Cells Begins in Japan

The first clinical trial to treat corneal disease using iPS cell-derived corneal tissue has commenced at Osaka University Hospital in Japan, aiming to restore vision for patients. The company conducting the trial plans to seek national approval in two years.